GlassScriptPhysician profile
Anil Kachru
NPI 1982679346
$9,821.46
in general payments reported to CMS, 2019-2025
39 companies · $2,145 in 2025
The $2,145 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $403 · 2021: $1,919 · 2022: $2,294 · 2023: $1,507 · 2024: $840 · 2025: $2,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,062 · Travel and Lodging: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,061.69 |
| Travel and Lodging | $1,430.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,488.28 | 2021-2022 | |
| Intuitive Surgical, INC. | $1,447.76 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $995.07 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Genzyme Corporation | $979.99 | 2021-2025 | |
| Glaxosmithkline, LLC. | $831.82 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $481.53 | 2019-2024 | Yupelri |
| Baxter Healthcare | $420.32 | 2021-2023 | Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $400.96 | 2021-2025 | Dupixent |
| Electromed, INC. | $388.87 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $356.97 | 2022-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.93 | 2020-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $219.13 | 2022-2023 | Wakix |
| Gilead Sciences, INC. | $157.79 | 2021-2025 | Livdelzi |
| Inspire Medical Systems, INC. | $151.63 | 2022-2024 | Inspire |
| Philips North America LLC | $150.58 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $147.66 | 2020-2024 | Prolastin-C Liquid |
| Genentech USA, INC. | $127.43 | 2019-2021 | |
| Amgen INC. | $96.05 | 2022-2025 | Tezspire |
| Pfizer INC. | $80.03 | 2019-2020 | |
| Inogen, INC. | $71.96 | 2022-2024 | |
| Verona Pharma, INC. | $67.17 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $57.94 | 2019-2020 | |
| Viatris Specialty LLC | $54.12 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $50.51 | 2023-2024 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $46.68 | 2019-2021 | |
| Insmed, INC. | $39.82 | 2025 | Arikayce |
| Boston Scientific Corporation | $28.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $25.99 | 2020 | |
| Shionogi INC | $24.75 | 2022 | |
| Allergan, INC. | $24.48 | 2019 | |
| Vapotherm INC | $24.32 | 2021 | |
| Abbvie INC. | $22.87 | 2024 | |
| Ceribell, INC. | $21.56 | 2025 | Pocket Eeg Device |
| Jazz Pharmaceuticals INC. | $21.24 | 2021 | |
| United Therapeutics Corporation | $20.99 | 2023 | Tyvaso |
| Lilly USA, LLC | $18.48 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $17.47 | 2021 | |
| Pulmonx Corporation | $15.87 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.44 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Kachru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.